Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-10-26 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2022 年第三季度报告" which translates to "2022 Third Quarter Report." It contains detailed financial data including income statements, balance sheets, cash flow statements, and notes for the third quarter of 2022. The document includes unaudited financial statements and management assurances about the accuracy and completeness of the quarterly report. The presence of comprehensive financial data for a period shorter than a full fiscal year (quarterly data) and the explicit mention of the third quarter period confirms this is an Interim / Quarterly Report. It is not an announcement or a brief summary but a full quarterly financial report with substantive financial data and analysis. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2022
2022-10-26 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of Shenzhen Huitai Medical Devices Co., Ltd. It details the stock price movements over specific dates, the company's internal investigation, confirmation of no undisclosed material information, and a risk warning to investors. There is no financial data, no report attached or referenced as being published, and no mention of annual or quarterly results. The document is a regulatory announcement about stock trading behavior and compliance with stock exchange rules, fitting the category of a Regulatory Filing (RNS).
2022-10-17 Chinese
关于深圳惠泰医疗器械股份有限公司股票交易异常波动问询函的回函
Regulatory Filings Classification · 95% confidence The document is a response letter from a controlling shareholder or actual controller to an inquiry about abnormal stock trading fluctuations. It explicitly states that the person has no undisclosed major information affecting stock price and no trading activity during the period. The document is short (451 characters) and is a formal reply to a regulatory inquiry rather than a financial report or announcement of a report. It does not contain financial data, management changes, or other report content. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2022-10-17 Chinese
2022年前三季度业绩预告的自愿性披露公告
Earnings Release Classification · 95% confidence The document is a voluntary earnings forecast announcement for the first three quarters of 2022 by Shenzhen Huitai Medical Devices Co., Ltd. It provides preliminary estimated net profit figures for the period from January 1 to September 30, 2022, compared to the previous year, and explicitly states that the forecast has not been audited by a registered accountant. The document is short (1027 characters) and does not contain actual financial statements or detailed financial analysis, but rather a forecast and risk warning. It also mentions that the final accurate financial data will be disclosed in the official third quarter report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only, rather than a full interim report or annual report. Therefore, the correct classification is Earnings Release (ER). 9M 2022
2022-10-16 Chinese
关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding the progress of the company's share repurchase through centralized bidding transactions. It details the number of shares repurchased, the price range, total funds used, and references previous announcements about the repurchase plan and report. The document does not contain financial statements or detailed financial analysis but is an update on the company's share buyback activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares.
2022-10-10 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司2022年半年度持续督导跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2022 Half-Year Continuous Supervision Tracking Report" issued by the sponsor institution (中信证券股份有限公司) for Shenzhen Huitai Medical Device Co., Ltd. It references the half-year period (1-6 months of 2022) and contains detailed financial data, risk disclosures, governance and compliance information, and updates on the use of raised funds. The document is comprehensive and contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not merely an announcement or a certification, but a full report with financial figures and management discussion. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2022-09-01 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.